Pharma Reaserch Prod Co Ltd (214450) — Cash Flow Reinvestment Rate
Pharma Reaserch Prod Co Ltd (214450) has a Cash Flow Reinvestment Rate of 1.20x as of December 2025, reinvesting ₩73.91 Billion (capex ₩7.79 Billion plus investments ₩-66.12 Billion) from operating cash flow of ₩61.53 Billion. Explore 214450 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pharma Reaserch Prod Co Ltd Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Pharma Reaserch Prod Co Ltd across 11 annual periods. Also explore 214450 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Pharma Reaserch Prod Co Ltd (2015–2025)
Year-by-year capital reinvestment analysis for Pharma Reaserch Prod Co Ltd. For live market cap and broader valuation context, see 214450 company net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.95x | ₩174.42 Billion | ₩183.16 Billion | ₩35.78 Billion | ▼ -49.6% |
| 2024 | 1.89x | ₩264.26 Billion | ₩139.88 Billion | ₩38.73 Billion | ▲ +112.0% |
| 2023 | 0.89x | ₩57.86 Billion | ₩64.95 Billion | ₩13.20 Billion | ▲ +78.4% |
| 2022 | 0.50x | ₩29.67 Billion | ₩59.40 Billion | ₩17.76 Billion | ▼ -62.6% |
| 2021 | 1.33x | ₩87.07 Billion | ₩65.30 Billion | ₩20.64 Billion | ▲ +12.4% |
| 2020 | 1.19x | ₩38.42 Billion | ₩32.39 Billion | ₩34.78 Billion | ▲ +110.6% |
| 2019 | 0.56x | ₩10.85 Billion | ₩19.27 Billion | ₩9.59 Billion | ▼ -94.5% |
| 2018 | 10.15x | ₩52.80 Billion | ₩5.20 Billion | ₩28.60 Billion | ▲ +603.0% |
| 2017 | 1.44x | ₩12.35 Billion | ₩8.56 Billion | ₩7.63 Billion | ▲ +200.7% |
| 2016 | 0.48x | ₩3.92 Billion | ₩8.16 Billion | ₩1.96 Billion | ▼ -93.5% |
| 2015 | 7.43x | ₩119.09 Billion | ₩16.02 Billion | ₩462.99 Million | — |